Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Patient advocacy session on treatment adherence

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.07.11
Views: 5928

Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK

The patient advocacy session at the 2011 EHA congress considered the importance of patient compliance with treatment schedules. It has been shown that patient compliance has a huge impact on treatment outcome and this is especially important in chronic myeloid leukaemia (CML) where patients must continue to take medication for their entire life. Giora Sharf and Dr Lina Eliasson speak to ecancer.tv about research into CML patient compliance which revealed that one quarter of patients missed over 10% of doses. The panel outline some of the reasons why patients miss their medication, outline steps clinicians can take to increase patient adherence and discuss international variations and the degree to which patients exaggerate their compliance.

Related videos

follow us

NCRI 2018

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence